Elevance Health IncELV
Price$381.67Intrinsic value$389.772% above price

Outlook & Key Dates

Estimates, guidance, catalysts, and upcoming events

Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
3.9%projected annual EPS growth
As of 27 Aug 2026
Analyst Coverage
21analysts covering
As of 18 Aug 2026
FY EPS (est.)
$27.16next fiscal year
As of 18 Aug 2026
Reporting Calendar
EventExpected Date
Q3 2026 Earnings Release21 Oct 2026
Monitoring Framework
Key Performance Indicators
Benefit Expense Ratio (Medical Loss Ratio) Quarterly89.7%Target: Prudent management of government business cost trends
Medical Membership Quarterly44.9MTarget: Stabilization of Medicaid and Individual ACA attrition
Days in Claims Payable (DCP) Quarterly45.4Target: Maintain stable reserve levels
Watch Items
  • Medicaid Operating Margin and Rate AlignmentTrigger: Operating margin below -1.75% or delayed state rate adjustmentsAction: Accelerate planned exits from unsustainable state Medicaid markets over the next 12 to 18 months
  • Medicare Advantage Operating Margin RecoveryTrigger: Operating margin falling below the 2% target for 2026Action: Re-evaluate product positioning, pricing, and geographic footprint
Sign in / Sign up to read more

Research as of 2 Sep 2026

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.